NurExone Biologic, Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: CA67059R1091

CAD

0.70

-0.07 (-9.09%)

Dec 04

TSX

Click here to see other stocks

Company CV

About NurExone Biologic, Inc.

stock-summary

NurExone Biologic, Inc.

Pharmaceuticals & Biotechnology

EnerSpar Corp, formerly Walmer Capital Corp, is a Canada-based capital-pool company. The Company's business is to identify and evaluate businesses and assets with a view to completing a qualifying transaction. The Company has not conducted commercial operations. The Company has not generated any revenue.

Company Coordinates

Company Details

22 Coulson Ave. , TORONTO ON : M4V 1Y5

stock-summary

Tel: 1 416 4105297

stock-summary

https://enerspar.com

stock-summary

Registrar Details

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Board of Directors

Management

Designation

Mr. James Richardson

Chairman of the Board, Chief Executive Officer

Mr. John Arnold

Chief Financial Officer, Corporate Secretary, Director

Mr. Peter Andrews

Director

Mr. John-Peter Bradford

Director

Stock DNA

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-3 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 41 Million ()

P/E

NA (Loss Making)

Industry P/E

NA

Dividend Yield

0.00%

Debt Equity

-0.83

Return on Equity

-327.74%

Price to Book

19.38